NCT05290896

Brief Summary

To assess correlations between lens star biometry parameters and phacoemulsification in clinical practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2022

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 12, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 22, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

6 months

First QC Date

March 12, 2022

Last Update Submit

March 12, 2022

Conditions

CataractLens DiseasesLens Opacities

Keywords

Cataract

Outcome Measures

Primary Outcomes (1)

  • Correlation between parameters measured by lens star.

    Anterior chamber depth, lens, axial length, keratometry readings and age of the patients.

    Immediately before phacoemulsification surgery

Study Arms (1)

Lens star biometry

OTHER

Biometry done prior to phacoemulsification

Device: Phacoemulsification

Interventions

PhacoemulsificationDEVICE

Phacoemulsification for senile cataract.

Also known as: Phaco
Lens star biometry

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients that will undergone phacoemulsification for their mild to moderate senile cataracts.

You may not qualify if:

  • congenital and developmental cataract.
  • cases with congenital lens anomalies as ectopia lentis and spheophakia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abdelshafy

Banhā, QA, 13511, Egypt

RECRUITING

MeSH Terms

Conditions

CataractLens Diseases

Interventions

Phacoemulsification

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

Cataract ExtractionRefractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, OperativeUltrasonic Surgical Procedures

Study Officials

  • Ahmed A Abdelshafy, MD

    Benha University

    PRINCIPAL INVESTIGATOR

  • Marwa A Abdelshafy, MD

    Benha University

    STUDY DIRECTOR

Central Study Contacts

Ahmed Abdelshafy, MD

CONTACT

01222328766ahmad4lg@gmail.com

Marwa Abdelshafy, MD

CONTACT

01222328766drmarwatabl2012@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Senile cataract patients
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Ophthalmology

Study Record Dates

First Submitted

March 12, 2022

First Posted

March 22, 2022

Study Start

February 20, 2022

Primary Completion

August 30, 2022

Study Completion

September 15, 2022

Last Updated

March 22, 2022

Record last verified: 2022-03

Locations

EG(1)